Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia

Clofarabine is an immunosuppressive purine nucleoside analog that may have better anti-leukemic activity than fludarabine. We performed a prospective phase I/II multisite trial of clofarabine with 2 Gy total body irradiation as non-myeloablative conditioning for allogeneic hematopoietic cell transpl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Krakow, Elizabeth F., Gyurkocza, Boglarka, Storer, Barry E, Chauncey, Thomas R., McCune, Jeannine S., Radich, Jerald P., Bouvier, Michelle E., Estey, Elihu H., Storb, Rainer, Maloney, David G, Sandmaier, Brenda M.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904507/
https://ncbi.nlm.nih.gov/pubmed/31637757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25665
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars